Literature DB >> 25245022

[Psoriasis-associated keratitis: case report].

F S Filev1, V G Herbert, B Lögering, V von Gruben, K Reich, M Klemm.   

Abstract

Psoriasis is a common skin disease, which is associated with multiple extracutaneous manifestations. This article presents a case report of a rare ocular manifestation of psoriasis; psoriasis-associated keratitis. In a 37-year-old man we could show that systemic immunomodulatory therapy led to a rapid improvement of the ocular symptoms.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25245022     DOI: 10.1007/s00347-014-3115-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  5 in total

1.  Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease.

Authors:  J R Smith; R D Levinson; G N Holland; D A Jabs; M R Robinson; S M Whitcup; J T Rosenbaum
Journal:  Arthritis Rheum       Date:  2001-06

Review 2.  Ocular psoriasis.

Authors:  Balvinder Rehal; Bobeck S Modjtahedi; Lawrence S Morse; Ivan R Schwab; Howard I Maibach
Journal:  J Am Acad Dermatol       Date:  2011-05-06       Impact factor: 11.527

3.  Biologic response modifier therapy for psoriatic ocular inflammatory disease.

Authors:  Nancy Huynh; Rene A Cervantes-Castaneda; Pooja Bhat; Michael J Gallagher; C Stephen Foster
Journal:  Ocul Immunol Inflamm       Date:  2008 May-Jun       Impact factor: 3.070

4.  Psoriasis and intraocular inflammation.

Authors:  D L Knox
Journal:  Trans Am Ophthalmol Soc       Date:  1979

5.  Ocular findings in patients with psoriasis.

Authors:  Berna Kilic; Umit Dogan; Ali Haydar Parlak; Nadir Goksugur; Mualla Polat; Didem Serin; Sedat Ozmen
Journal:  Int J Dermatol       Date:  2013-01-20       Impact factor: 2.736

  5 in total
  1 in total

Review 1.  Identifying and Treating Ocular Manifestations in Psoriasis.

Authors:  Mahsaw Motlagh; Christopher Fortenbach; Howard I Maibach; Bobeck S Modjtahedi
Journal:  Am J Clin Dermatol       Date:  2021-11-03       Impact factor: 7.403

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.